French biotech Enodia Therapeutics is paying $1 million upfront in a backloaded deal for Kezar Life Sciences’ preclinical protein degradation program. | French biotech Enodia Therapeutics is paying $1 ...

New educational programs aim to expand access to practical neuroscience-based tools for practitioners, families, and individuals in recovery. WAYNE, W.Va., March 10, 2026 /PRNewswire/ -- Eating ...

BOSTON--(BUSINESS WIRE)--BPGbio, Inc., a leading biology-first, AI-powered, clinical stage biopharma focused on mitochondrial biology and protein homeostasis, today announced its participation in then ...

Protein, often hailed as the building block of life, plays a fundamental role in numerous bodily functions, from muscle growth and repair to immune system support and enzyme production. While its ...